Superior vena cava syndrome caused by chemotherapy-induced fibrosis.
We report a case of a 51-year old man with small cell lung cancer who developed superior vena cava syndrome due to obstruction of the superior vena cava at the junction of the brachiocephalic vein by a fibrotic band, 2 months after completing six cycles of chemotherapy with cisplatin and etoposid. Superior vena cava syndrome caused by chemotherapy-induced pulmonary fibrosis should be kept in mind during follow-up.
Turk
H M
HM
Gaziantep University, Faculty of Medicine, Department of Medical Oncology, Turkey.
Camci
C
C
Buyukberber
S
S
Tuncozgur
B
B
Sivrikoz
C
C
Elbeyli
L
L
Sari
I
I
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D018288:Carcinoma, Small Cell / Q000188:drug therapy / Q000473:pathology; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005355:Fibrosis; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D013479:Superior Vena Cava Syndrome / Q000139:chemically induced* / Q000175:diagnosis; D014683:Vena Cava, Superior / Q000187:drug effects / Q000473:pathology*
D005047:Etoposide; D002945:Cisplatin